We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




World’s First Automated Tissue Grossing Platform Uses AI to Assess Specimens

By LabMedica International staff writers
Posted on 13 Jul 2022

A first-of-its-kind pathology processing platform is designed to seamlessly deliver a range of solutions for critical lab processes. More...

The tissue grossing platform automates the process of receiving, assessing, and processing tissue samples. The platform uses a high-quality video system combined with AI to assess specimens and create a gross report 93% faster than human technicians with 43% more accuracy.

The Sentinel from VistaPath Biosystems (Cambridge, MA, USA) is the world’s first automated tissue grossing platform, offering the easiest, safest way to gross tissues. The Sentinel is the only platform that can allow labs to image specimens, generate gross reports and approve them remotely; shaving hours off their specimen turnaround time. The sample container and cassette are placed into the Sentinel, where an image of the tissue and the container label is taken. The Sentinel continuously checks the container and cassettes being used to guarantee specimens cannot be mixed up. As the tissue is transferred into the cassette, the Sentinel locates, measures, and captures an image of each piece of tissue. A gross report is automatically generated using the laboratory’s own template. The technician approves the report which is transferred to the patient’s record.

The Sentinel automatically locates, measures, and images tissue as it is placed into the cassette, all in under a second. Its measurements are more accurate and consistent than from technicians. The Sentinel ensures that errors do not occur in the laboratory’s process by constantly reading all labeling and locks out and notifies the user if a mismatch occurs. It monitors all tissue before, during and after transfer from the container to the cassette ensuring no tissue is lost or left behind. The Sentinel provides the most robust record of specimens as they are received and moved through the grossing process. Labs can print beautiful, full-color reports that provide the gross description, patient and clinician information and images of the container, container label and cassette.

Related Links:
VistaPath Biosystems 


New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Capillary Blood Collection Tube
IMPROMINI M3
New
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Platelets sequester cfDNA during circulation (Murphy L. et al., Science, 2025; DOI: 10.1126/science.adp3971)

Platelets Could Improve Early and Minimally Invasive Detection of Cancer

Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.